Family Medicine · Riverdale, GA
NPI
1780649368
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
33 Upper Riverdale Rd SW Ste 118
Riverdale, GA, 30274
Phone (770) 994-6969
Groups this clinician bills Medicare through
Medicare paid, 2024
$15K
425 services
Medicare patients, 2024
73
Average age 72
Drug cost, 2024
$1.8M
10,551 prescriptions
Company payments, 2025
$891
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James E Gleason Jr. was code 99214 (office e&m - established), 118 times for 58 patients. In total James E Gleason Jr. billed 425 services in 12 codes, and Medicare paid $15K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-01-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 118 | 58 | $75.64 | $8,926 |
| 36415 Venipuncture Blood Collection | Office | 94 | 50 | $8.65 | $813 |
| 81002 Clinical Chemistry | Office | 90 | 47 | $3.41 | $307 |
| 99213 Office E&M - Established | Office | 56 | 36 | $52.02 | $2,913 |
| 82962 Clinical Chemistry | Office | 35 | 23 | $3.21 | $112 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 11 | 11 | $127.91 | $1,407 |
By year: 2022 $17K for 490 services; 2023 $16K for 406 services; 2024 $15K for 425 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 94 | 50 | $8.65 | $813 |
| 81002 Clinical Chemistry | 90 | 47 | $3.41 | $307 |
| 82962 Clinical Chemistry | 35 | 23 | $3.21 | $112 |
Medicare prescription drug claims, 2024
In 2024, the drug James E Gleason Jr. prescribed most often to Medicare patients was Amlodipine Besylate, with 524 prescriptions and refills. In total James E Gleason Jr. wrote 10,551 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 524 | 1,426 | 158 | $2,164 |
| Montelukast Sodium Generic | 484 | 1,312 | 173 | $4,689 |
| Jardiance Empagliflozin | 351 | 637 | 78 | $372K |
| Losartan Potassium Generic | 345 | 860 | 89 | $2,963 |
| Metformin Hcl Er Metformin Hcl | 265 | 674 | 80 | $1,344 |
| Mounjaro Tirzepatide | 259 | 302 | 45 | $317K |
| Alprazolam Generic | 238 | 238 | 29 | $1,096 |
| Atorvastatin Calcium Generic | 230 | 582 | 63 | $1,502 |
| Hydrochlorothiazide Generic | 214 | 607 | 69 | $885 |
| Spironolactone Generic | 200 | 528 | 57 | $1,252 |
| Tizanidine Hcl Generic | 183 | 281 | 52 | $2,273 |
| Acetaminophen-Codeine Acetaminophen With Codeine | 177 | 180 | 24 | $8,022 |
| Metoprolol Succinate Generic | 172 | 483 | 51 | $1,681 |
| Famotidine Generic | 157 | 391 | 50 | $1,264 |
| Hydroxyzine Hcl Generic | 156 | 194 | 51 | $1,764 |
Brand drugs: 1,755 claims; generic drugs: 8,687 claims; opioid claims: 304.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James E Gleason Jr. $891 ($891 in general payments such as food, travel and fees) from 11 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $223.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 6 | $223 |
| Abbvie Inc. ABBV | 9 | $203 |
| ViiV Healthcare Company GSK | 6 | $149 |
| Lilly USA, LLC LLY | 2 | $118 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $71.02 |
| Novo Nordisk Inc NVO | 1 | $25.93 |
| Idorsia Pharmaceuticals US Inc | 1 | $24.79 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $21.92 |
| Abbott Laboratories ABT | 1 | $19.74 |
| Exact Sciences Corporation EXAS | 1 | $17.49 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.